Vision Biotechnology

Vision Biotechnology is a rapidly scaling, commercial-stage diagnostics company with a significant global footprint. It operates as a diversified manufacturer and supplier, offering a broad range of products from nucleic acid extraction kits and real-time PCR tests to lateral flow assays and blood typing solutions, supported by OEM services. The company leverages R&D and manufacturing facilities across Turkey, Azerbaijan, Nigeria, the USA, and Germany to serve clinical laboratories, hospitals, and veterinary practices. Its established distributor network and multi-continent operations position it as a key player in the global in-vitro diagnostics (IVD) market.

Integrated manufacturer across multiple diagnostic modalities: PCR/molecular diagnostics, Lateral Flow and Fluorescence Immunoassays, Gel Card blood typing, microbiology culture media, and exploratory exosome production.

Vision Biotechnology operates in the highly competitive global IVD market, competing against large multinational corporations (e.g., Roche, Abbott) with vast R&D budgets and deep market penetration, as well as numerous regional and niche players. Its competitive edge is derived from a broad, cost-effective product portfolio, flexible OEM services, and an extensive distribution network in emerging markets.